These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10505723)

  • 21. Assessment of Helicobacter pylori infection.
    Bateson MC
    J R Soc Med; 1994 Mar; 87(3):125-6. PubMed ID: 8158584
    [No Abstract]   [Full Text] [Related]  

  • 22. How labile is gastric infection with H pylori?
    Hobsley M; Tovey FI; Holton J
    World J Gastroenterol; 2007 Sep; 13(35):4665-8. PubMed ID: 17729387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel agent for Helicobacter pylori infection management.
    Mohammadzadeh R; Ahmadiyan N
    Chin Med J (Engl); 2013 Dec; 126(23):4535. PubMed ID: 24286420
    [No Abstract]   [Full Text] [Related]  

  • 24. Helicobacter pylori induced apoptosis.
    Shirin H; Moss SF
    Gut; 1998 Nov; 43(5):592-4. PubMed ID: 9824331
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of the Microbiota and Gastric Disease Development by Helicobacter pylori.
    Alarcón T; Llorca L; Perez-Perez G
    Curr Top Microbiol Immunol; 2017; 400():253-275. PubMed ID: 28124157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High salt diet can down-regulate TFF2 expression level in gastric mucosa of MGs after H. pylori infection.
    Chen X; Hu Y; Xie Y; Wang Y
    Microb Pathog; 2018 May; 118():316-321. PubMed ID: 29601867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication, endoscopic surveillance, and gastric cancer.
    Cannizzaro R; De Paoli P
    Am J Gastroenterol; 2009 Dec; 104(12):3100-1; author reply 3101-2. PubMed ID: 19956127
    [No Abstract]   [Full Text] [Related]  

  • 28. Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment.
    Horstmann M; Erttmann R; Winkler K
    Lancet; 1994 Apr; 343(8905):1098-9. PubMed ID: 7909113
    [No Abstract]   [Full Text] [Related]  

  • 29. Helicobacter pylori and gastric lymphonodular hyperplasia in children.
    Rosh JR; Kurfist LA; Benkov KJ; Toor AH; Bottone EJ; LeLeiko NS
    Am J Gastroenterol; 1992 Jan; 87(1):135-9. PubMed ID: 1728111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori eradication treatment reduces but does not abolish the risk of gastric cancer.
    Fuccio L; Eusebi LH; Zagari RM; Bazzoli F
    Am J Gastroenterol; 2009 Dec; 104(12):3100; author reply 3101-2. PubMed ID: 19956126
    [No Abstract]   [Full Text] [Related]  

  • 31. [Helicobacter pylori, mycoplasmas, and gastric diseases].
    Rivera Tapia JA; Rodríguez Preval N
    Salud Publica Mex; 2005; 47(2):105-6. PubMed ID: 15889633
    [No Abstract]   [Full Text] [Related]  

  • 32. The effectiveness of systemic eradication therapy against oral Helicobacter pylori.
    Bago I; Bago J; Plečko V; Aurer A; Majstorović K; Budimir A
    J Oral Pathol Med; 2011 May; 40(5):428-32. PubMed ID: 21198868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intractable ulcer after the eradication of Helicobacter pylori].
    Taguchi Y; Imoto I
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():483-7. PubMed ID: 11979832
    [No Abstract]   [Full Text] [Related]  

  • 34. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease?
    Bayerdörffer E; Ritter MM; Hatz R; Brooks W; Ruckdeschel G; Stolte M
    Gut; 1994 May; 35(5):701-4. PubMed ID: 8200570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori-associated gastric pathology.
    Robert ME; Weinstein WM
    Gastroenterol Clin North Am; 1993 Mar; 22(1):59-72. PubMed ID: 8449571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Nobel Prize and pathology.
    Sternberg SS
    Am J Surg Pathol; 2003 Jun; 27(6):846-7. PubMed ID: 12766592
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastropathy and diarrhea in diabetic patients: the presence of helicobacteriosis and PAS-positive vascular deposits in gastric and duodenal mucosa.
    Ivandić A; Bozić D; Dmitrović B; Vcev A; Canecki S
    Wien Klin Wochenschr; 2001 Mar; 113(5-6):199-203. PubMed ID: 11293950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glutathione levels in Helicobacter pylori-infected gastric mucosa].
    Park DK; Jeong SK; Chung MG; Kwon OS; Kim SS; Koo YS; Kim YK; Kim YS; Choi DJ; Park CS; Chung WG; Kim JH
    Korean J Gastroenterol; 2003 Oct; 42(4):267-73. PubMed ID: 14634345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
    Cheung DY
    Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
    [No Abstract]   [Full Text] [Related]  

  • 40. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication.
    Rugge M
    Gastroenterol Clin North Am; 2015 Sep; 44(3):609-24. PubMed ID: 26314671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.